Showing results (121-130 of 136) with videos related to
Sort By:
Pageof 14
Japanese Journal of Clinical Oncology|October 8, 2021
Study protocol for NCCH1908 (UPFRONT-trial): a prospective clinical trial to evaluate the feasibility and utility of comprehensive genomic profiling prior to the initial systemic treatment in advanced solid tumour patientsTakaaki Mizuno, Tatsuya Yoshida, Kuniko Sunami, et al.Oncology|March 14, 2015
Distribution of Resistant Esophageal Adenocarcinoma in the Resected Specimens of Clinical Stage III Patients after Chemoradiation: Its Clinical ImplicationsNastaran Neishaboori, Roopma Wadhwa, Graciela M Nogueras-González, et al.Journal of the National Comprehensive Cancer Network : JNCCN|February 7, 2016
A Nomogram to Predict Distant Metastases After Multimodality Therapy for Patients With Localized Esophageal CancerKazuki Sudo, Xuemei Wang, Lianchun Xiao, et al.Oncology|April 30, 2018
Actionable Locoregional Relapses after Therapy of Localized Esophageal Cancer: Insights from a Large CohortElena Elimova, Xuemei Wang, Wei Qiao, et al.British Journal of Cancer|November 15, 2017
Galectin-3 expression is prognostic in diffuse type gastric adenocarcinoma, confers aggressive phenotype, and can be targeted by YAP1/BET inhibitorsJaffer A Ajani, Jeannelyn S Estrella, Qiongrong Chen, et al.Journal of Hematology & Oncology|February 10, 2026
Implementing generative artificial intelligence in precision oncology: safety, governance, and significanceRyuji Hamamoto, Takafumi Koyama, Satoshi Takahashi, et al.Breast Cancer : Basic and Clinical Research|November 4, 2024
Multicenter Prospective Study in HER2-Positive Early Breast Cancer for Detecting Minimal Residual Disease by Circulating Tumor DNA Analysis With Neoadjuvant Chemotherapy: HARMONY StudyMomoko Tokura, Mark Malalay Ando, Yuki Kojima, et al.JCO Precision Oncology|July 6, 2023
Pediatric Precision Medicine at the National Cancer Center Japan: Prospective Genomic Study of Pediatric Patients with Cancer as Part of the TOP-GEAR ProjectKayoko Tao, Fumito Yamazaki, Takashi Kubo, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 26, 2023
Tucatinib and Trastuzumab for Previously Treated Human Epidermal Growth Factor Receptor 2-Positive Metastatic Biliary Tract Cancer (SGNTUC-019): A Phase II Basket StudyYoshiaki Nakamura, Nobumasa Mizuno, Yu Sunakawa, et al.Breast Cancer (Tokyo, Japan)|June 24, 2026
Quality of life with palbociclib plus tamoxifen in hormone receptor-positive, HER2-negative advanced breast cancer: results from PATHWAY, an Asian international, double-blind, randomized phase 3 trialTakashi Yamanaka, Joohyuk Sohn, Kazuki Sudo, et al.Pageof 14